Navigation Links
Webcast Alert: Kaiser Permanente Residency Program Open House
Date:8/31/2007

SANTA CLARA, Calif., Aug. 31 /PRNewswire/ -- In September medical students begin searching for residency training programs to apply all they have learned. With college loans entering repayment, medical students have fewer dollars to visit a wide variety of residency programs. Kaiser Permanente, a leader in graduate medical education and technology, is responding to this need by hosting an in-person and virtual Residency Open House on September 8, 2007. Medical students nationwide have the opportunity to meet program directors and learn from current residents what it is like to train in Kaiser Permanente's world class health care delivery system. Students are encouraged to submit questions in advance for the "Ask a Resident" session featured at this in-person and webcast event. For in-person or virtual attendance, register at http://residency.kp.org/ncal/

What: Kaiser Permanente Residency Program Open House

When: Saturday, September 8, 2007 10:30am-12:00pm PDT

Where: http://www.videonewswire.com/event.asp?id=41827

How: Live over the Internet -- Simply log on to the web at the

address above.

Contact: Lisa Lau (510) 625-2102

Minimum Requirements to listen to broadcast:

The Windows Media Player software, downloadable free from http://www.microsoft.com and at least a 56Kbps connection to the Internet. If you experience problems listening to the webcast, send an E-mail to: webcast@multivu.com.


'/>"/>
SOURCE Kaiser Permanente
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related medicine news :

1. Mumbai Alert: Possibility Of An Epidemic Outbreak
2. Europe On High Bird Flu Alert: European Commission
3. Bird Flu Alert: Kuwait
4. Public Alert: Beware of fake glucose test strips!!
5. Computer Program can assist to detect Heart Attack
6. Advanced STD programs required
7. Self-Management Program Beneficial for Back Pain
8. Self-Management Program Beneficial for Back Pain
9. Disease Management Programs – Effective for Heart Patient
10. Suicide Prevention Program – Having its Intended Effec
11. Cardiac – Rehabilitation Programs Beneficial for Heart Patient
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...mab) drug is found to be useful in treating patien... by the European Medicines Agency (EMEA) for use i...rrent drugs//. Xolair can be used in the treatment...effects of the new drug on long time usage has to ...
... suggests that the melanocortin system is an impor...al neuronal plasticity observed after chronic morp... is accompanied by the development of morphine tol...ms associated with opiate treatment. Possible modu...
...m Italy have designed a closed circuit, where Umbi...n are performed, in order to reduce the contaminat...n//. Their findings appear in the journal Blood C...le online 19 August 2005)Umbilical cord blood is a...
...cal tourism is currently the buzz word of Indian h...g from USA and Canada for niche high cost orthoped...e replacement. // The fact that surgeries by many... and they have wide experience helps to win over t...
Other Medicine News:Health News:Inhibition of morphine tolerance by spinal melanocortin receptor blockade 2Health News:A Novel System For Clinical Banking Of Umbilical Cord Blood 2Health News:India - Favored Orthopedics Surgery Destination 2Health News:India - Favored Orthopedics Surgery Destination 3
(Date:9/5/2008)...lif., Sept. 5 /- SARcode,Co...cule LFA-1 inhibitors,to treat inflammatory diseas...S) today announced SARcode,s initiation of a Phase...t candidate for T-cell mediated ophthalmic,disease...ement providing,SARcode with an exclusive license ...
(Date:9/4/2008)...ept. 4 /- Cytopia Limited (ASX:,CYT) ...r its Phase Ib/II,study of CYT997, the company,s n...ents with an aggressive form of brain cancer known...cal trial is the first Phase II efficacy study in ...ompany and the second in its,suite of Phase II stu...
(Date:9/4/2008)...Man(R) real-time PCR testing for the diagnostic ...alif., Sept. 4 /- The U.S. Food & Dru...S(R) TaqMan(R) HBV Test,the first assay for quant...,The test uses Roche,s real-time PCR technology to... patient,s blood. Doctors may use viral load,testi...
(Date:9/4/2008)... 4 /- Southern Research Institute,tod...h (NIH) has selected,the organization to participa...roduction Center Network (MLPCN). The MLPCN -- a c...lecular Libraries Program which is,designed to ben... the human,genome and validate future targets for ...
Breaking Medicine Technology:SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Coalition of Caregivers Warns Congress of Danger to Oldest U S Seniors if Medicare Slashed 5228 1Coalition of Caregivers Warns Congress of Danger to Oldest U S Seniors if Medicare Slashed 5228 2Coalition of Caregivers Warns Congress of Danger to Oldest U S Seniors if Medicare Slashed 5228 3Coalition of Caregivers Warns Congress of Danger to Oldest U S Seniors if Medicare Slashed 5228 4New ActivePure Technology Proven To Reduce Exposure to Methicillin Resistant Staphylococcus Aureus 28MRSA 29 1653 1New ActivePure Technology Proven To Reduce Exposure to Methicillin Resistant Staphylococcus Aureus 28MRSA 29 1653 2Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences 1649 1Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences 1649 2Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences 1649 3Mayo Clinic Study Shows Drug Could Effectively Treat Prevent the Spread of Breast Cancer 720 1Mayo Clinic Study Shows Drug Could Effectively Treat Prevent the Spread of Breast Cancer 720 2Mayo Clinic Study Shows Drug Could Effectively Treat Prevent the Spread of Breast Cancer 720 3
...Abbott,s Bioabsorbable Stent Technology Holds Prom...icians Treating Patients,with Coronary Artery Dise...-FirstCall/ --,Abbott today announced positive res... evaluating the overall safety and performance,of ... for the,treatment of coronary artery disease. Six...
...Initial Analysis Shows Statistically Significant C... ALTO, Calif., March 26, 2007 /PRNewswire-FirstCal... positive initial,results from its Phase IIa clini...zophrenic patients with acute agitation. The 10 mg...inical trial,which was a statistically-significan...
Other Medicine Technology:Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent 2Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent 3Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 2Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 3Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 4Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 5Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 6
...nd medium volume laboratories, as well as specialt...simplicity and flexibility needed to respond to mu... the Elecsys 1010 system enables operators to hand...e testing without sacrificing ease of operation or...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t
...stry System provides high-performance detection te...c proteins and therapeutic drugs. It also delivers...ow the laboratory to streamline its operations and...esign enables numerous functions to be performed s...
The Embla 384 cell washer is a top-loading, robotic-compatible microplate washer for high throughput screening. It is designed specifically for cell-based assays, which require a gentler wash, but ca
Medicine Products: